Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma

Clinical trial NCT03323034 · COMPLETED

Trial details

NCT number: NCT03323034
Sponsor: Children's Oncology Group
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Lymphoma Recurrent Malignant Solid Neoplasm Recurrent Primary Central Nervous System Neoplasm Refractory Lymphoma Refractory Malignant Solid Neoplasm Refractory Primary Central Nervous System Neoplasm

Start date: 2018-01-11
Primary completion: 2021-09-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.